CAS Medical Systems, Inc. (CASM) Hit 1-Year High on May, 16

May 16, 2018 - By Sonya McDaniel

CAS Medical Systems, Inc. (NASDAQ:CASM) Corporate Logo

Big Money Sentiment increased to 1 in 2017 Q4. It has change of 0.17, from 2017Q3’s 0.83. The ratio increased due to CAS Medical Systems, Inc. positioning: 2 sold and 3 reduced. 3 funds acquired stakes and 2 increased stakes. Investors holded 6.37 million in 2017Q3 but now own 6.42 million shares or 0.78% more.
Morgan Stanley, a New York-based fund reported 721 shs. Royal Savings Bank Of Canada reported 0% in CAS Medical Systems, Inc. (NASDAQ:CASM). Vanguard Group invested 0% of its capital in CAS Medical Systems, Inc. (NASDAQ:CASM). 38,175 are held by Td Capital Management Limited Co. Northern Tru Corporation has 25,101 shs. Penbrook Mgmt Ltd Liability Company has 0.02% invested in CAS Medical Systems, Inc. (NASDAQ:CASM) for 33,600 shs. Renaissance Tech Limited Liability Corporation stated it has 270,000 shs. Rmb Cap Management Ltd Liability Com has 20,000 shs for 0% of their capital. California Public Employees Retirement Sys accumulated 10,400 shs. Acuta Capital Ptnrs Ltd Co holds 0.75% or 5.16 million shs. Citadel Advsrs Limited Liability Corp invested in 32,680 shs or 0% of the stock. Guggenheim Capital Ltd Liability Corporation reported 12,172 shs stake. California-based Wells Fargo And Mn has invested 0% in CAS Medical Systems, Inc. (NASDAQ:CASM). Blackrock Incorporated stated it has 0% of its capital in CAS Medical Systems, Inc. (NASDAQ:CASM). Hightower Advsrs Ltd Liability Corporation invested in 245,489 shs or 0% of the stock.

CAS Medical Systems, Inc. had 1 sale and 2 buys since January 4, 2018. This’s net activity of $441,587. On Thursday, March 15 Shares for $3,489 were sold by Gamelin John.

Today CAS Medical Systems, Inc. (NASDAQ:CASM) with $1.49 price per share, touched yearly high with $1.62 target or 9.00 % above. It was published on May, 16 according to Barchart.com. The company has $40.87 million market cap. At our $1.62 target, the company worth will be $3.68 million more.

The stock increased 10.37% or $0.14 during the last trading session, reaching $1.49.CAS Medical Systems, Inc. is downtrending after having declined 14.97% since May 16, 2017. CASM has 631,805 volume or 1537.78% up from normal. CASM underperformed the S&P500 by 26.52%.

On August, 14 is awaited CAS Medical Systems, Inc. (NASDAQ:CASM)’s earnings report, according to Faxor. This year’s EPS analyst estimate is awaited to be $-0.07. That is 22.22 % up compareed to $-0.09 EPS for last year. Wall Street predicts 0.00 % EPS growth as of August, 14.

More recent CAS Medical Systems, Inc. (NASDAQ:CASM) news were announced by Globenewswire.com, Nasdaq.com and Seekingalpha.com. The first one has “FDA Clears CASMED’s FORE-SIGHT Tissue Oximetry OEM Module” as a title and was announced on May 16, 2018. The next is “CASMED to Report First-Quarter 2018 Financial Results and Hold Conference Call on May 10” on May 03, 2018. And last was announced on May 12, 2018, called “CAS Medical Systems’ (CASM) CEO Tom Patton on Q1 2018 Results – Earnings Call Transcript”.

CAS Medical Systems, Inc., a non-invasive cerebral oximetry technology company, develops, makes, and markets non-invasive patient monitoring products worldwide.The firm is worth $40.87 million. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides non-invasive and continuous measurement of absolute cerebral tissue oxygenation in the brain for patients during critical care.Last it reported negative earnings. The firm provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories.

CAS Medical Systems, Inc. (NASDAQ:CASM) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.